Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Sep 20, 2023 6:18pm
137 Views
Post# 35646291

RE:RE:Oh not again...

RE:RE:Oh not again...embarrassed because of your comments, are you back on the Class A drugs again Azzak ??

Petty digs are meaningless.. I care only about trading this pos... whilst you and pumper crowd have been wrong on this stock for years. The PPS is down 95% since the company started, and they've been advancing towards a Phase III in mBC for 5 years (IND213 started in 2012 for ffs) .. this goon management is clueless.. The market has spoken, almost zero instituiotnal interest, paultry market cap, and a product that Big Pharma has turned its nose up at time and time again, there is no white knoight coming to rescue Oncolytics. . even Adlai Notrtye has abandoned Pela... LOL... You unicorn hunters really are open to a big disappointment.

Today is Day 90... WHERE is the announcement on PanCan Matt..???.

Denial isn't just a river in Africa old bean..  LOL, nuts. 

Fireside chat... oh jeez... it'll be same old, same old.


<< Previous
Bullboard Posts
Next >>